Literature DB >> 20739394

TNFR1-deficient mice display altered blood pressure and renal responses to ANG II infusion.

Chun Cheng Andy Chen1, Paulina L Pedraza, Shoujin Hao, Charles T Stier, Nicholas R Ferreri.   

Abstract

The hypothesis that TNF receptor 1-deficient (TNFR1(-/-)) mice display blood pressure (BP) and renal functional responses that differ from wild-type (WT) mice was tested in an angiotensin II (ANG II)-dependent model of hypertension. Basal systolic BP (SBP), mean arterial pressure, diastolic BP, heart rate (HR), and pulse pressure were similar in WT and TNFR1(-/-) mice. Infusion of ANG II for 7 days elevated SBP to a greater extent in TNFR1(-/-) compared with WT mice; pulse pressure was also elevated in TNFR1(-/-). HR decreased in TNFR1(-/-) mice infused with ANG II, an effect prominent on day 1. Basal urinary albumin excretion was similar in WT and TNFR1(-/-) mice but was higher in TNFR1(-/-) in response to ANG II infusion. Water intake and urine volume were increased by ANG II infusion; this increase was higher in TNFR1(-/-) vs. WT mice, whereas body weight and food intake were unaffected. Baseline creatinine clearance (Ccr), urinary sodium excretion, and fractional excretion of sodium (FE(Na)%) were similar in vehicle-treated WT and TNFR1(-/-) mice. ANG II infusion for 7 days increased Ccr and filtered load of sodium in TNFR1(-/-) but not WT mice, whereas it elicited an increase in FE(Na)% and urinary sodium excretion in WT but not TNFR1(-/-) mice. ANG II also inhibited renal TNFR1 mRNA accumulation while increasing that of TNFR2. These findings indicate deletion of TNFR1 is associated with an exacerbated SBP response, decrease in HR, and altered renal function in ANG II-dependent hypertension.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20739394      PMCID: PMC2980415          DOI: 10.1152/ajprenal.00344.2010

Source DB:  PubMed          Journal:  Am J Physiol Renal Physiol        ISSN: 1522-1466


  48 in total

1.  Angiotensin II-induced hypertension in bradykinin B2 receptor knockout mice.

Authors:  L Cervenka; J Maly; L Karasová; M Simová; S Vítko; S Hellerová; J Heller; S S El-Dahr
Journal:  Hypertension       Date:  2001-03       Impact factor: 10.190

2.  Tumor necrosis factor receptor 2 gene (TNFRSF1B) in genetic basis of coronary artery disease.

Authors:  A V Benjafield; X L Wang; B J Morris
Journal:  J Mol Med (Berl)       Date:  2001-04       Impact factor: 4.599

3.  Pulse pressure not mean pressure determines cardiovascular risk in older hypertensive patients.

Authors:  J Blacher; J A Staessen; X Girerd; J Gasowski; L Thijs; L Liu; J G Wang; R H Fagard; M E Safar
Journal:  Arch Intern Med       Date:  2000-04-24

4.  Role of TNFR1 and TNFR2 receptors in tubulointerstitial fibrosis of obstructive nephropathy.

Authors:  G Guo; J Morrissey; R McCracken; T Tolley; S Klahr
Journal:  Am J Physiol       Date:  1999-11

5.  Sex differences in adaptive downregulation of pre-macula densa sodium transporters with ANG II infusion in mice.

Authors:  Swasti Tiwari; Lijun Li; Shahla Riazi; Veerendra K Madala Halagappa; Carolyn M Ecelbarger
Journal:  Am J Physiol Renal Physiol       Date:  2009-11-04

6.  Cutting edge: TNFR-shedding by CD4+CD25+ regulatory T cells inhibits the induction of inflammatory mediators.

Authors:  Geertje J D van Mierlo; Hans U Scherer; Marjolijn Hameetman; Mary E Morgan; Roelof Flierman; Tom W J Huizinga; René E M Toes
Journal:  J Immunol       Date:  2008-03-01       Impact factor: 5.422

7.  Expression and function of NFAT5 in medullary thick ascending limb (mTAL) cells.

Authors:  Shoujin Hao; Hong Zhao; Zbigniew Darzynkiewicz; Sailaja Battula; Nicholas R Ferreri
Journal:  Am J Physiol Renal Physiol       Date:  2009-04-15

8.  Involvement of tumor necrosis factor-alpha in angiotensin II-mediated effects on salt appetite, hypertension, and cardiac hypertrophy.

Authors:  Srinivas Sriramula; Masudul Haque; Dewan S A Majid; Joseph Francis
Journal:  Hypertension       Date:  2008-04-07       Impact factor: 10.190

9.  Possible association of tumor necrosis factor receptor 2 gene polymorphism with severe hypertension using the extreme discordant phenotype design.

Authors:  Takashi Eguchi; Tatsuya Maruyama; Yoichi Ohno; Toshiyuki Morii; Keiichi Hirao; Hiroshi Hirose; Hiroshi Kawabe; Ikuo Saito; Matsuhiko Hayashi; Takao Saruta
Journal:  Hypertens Res       Date:  2009-06-26       Impact factor: 3.872

10.  Tumor necrosis factor-alpha induces renal vasoconstriction as well as natriuresis in mice.

Authors:  Mohd Shahid; Joseph Francis; Dewan S A Majid
Journal:  Am J Physiol Renal Physiol       Date:  2008-10-15
View more
  29 in total

1.  Tumor necrosis factor-alpha is an endogenous inhibitor of Na+-K+-2Cl- cotransporter (NKCC2) isoform A in the thick ascending limb.

Authors:  Sailaja Battula; Shoujin Hao; Paulina L Pedraza; Charles T Stier; Nicholas R Ferreri
Journal:  Am J Physiol Renal Physiol       Date:  2011-04-20

Review 2.  The inextricable role of the kidney in hypertension.

Authors:  Thomas M Coffman
Journal:  J Clin Invest       Date:  2014-06-02       Impact factor: 14.808

Review 3.  Renal effects of cytokines in hypertension.

Authors:  Yi Wen; Steven D Crowley
Journal:  Curr Opin Nephrol Hypertens       Date:  2018-03       Impact factor: 2.894

4.  Cytochrome P450 1B1 contributes to renal dysfunction and damage caused by angiotensin II in mice.

Authors:  Brett L Jennings; Larry J Anderson; Anne M Estes; Fariborz A Yaghini; Xiao R Fang; Jason Porter; Frank J Gonzalez; William B Campbell; Kafait U Malik
Journal:  Hypertension       Date:  2011-12-19       Impact factor: 10.190

Review 5.  Eicosanoids and tumor necrosis factor-alpha in the kidney.

Authors:  Nicholas R Ferreri; Shoujin Hao; Paulina L Pedraza; Bruno Escalante; Carlos P Vio
Journal:  Prostaglandins Other Lipid Mediat       Date:  2011-11-11       Impact factor: 3.072

Review 6.  Inflammation and hypertension: new understandings and potential therapeutic targets.

Authors:  Carmen De Miguel; Nathan P Rudemiller; Justine M Abais; David L Mattson
Journal:  Curr Hypertens Rep       Date:  2015-01       Impact factor: 5.369

Review 7.  Tumor necrosis factor-α, kidney function, and hypertension.

Authors:  Eamonn Mehaffey; Dewan S A Majid
Journal:  Am J Physiol Renal Physiol       Date:  2017-07-19

8.  TNF-α type 2 receptor mediates renal inflammatory response to chronic angiotensin II administration with high salt intake in mice.

Authors:  Purnima Singh; Laleh Bahrami; Alexander Castillo; Dewan S A Majid
Journal:  Am J Physiol Renal Physiol       Date:  2013-02-06

Review 9.  The cooperative roles of inflammation and oxidative stress in the pathogenesis of hypertension.

Authors:  Steven D Crowley
Journal:  Antioxid Redox Signal       Date:  2013-04-19       Impact factor: 8.401

10.  TNF receptor 1 signaling is critically involved in mediating angiotensin-II-induced cardiac fibrosis.

Authors:  Clemens Duerrschmid; Jeffrey R Crawford; Erin Reineke; George E Taffet; Joann Trial; Mark L Entman; Sandra B Haudek
Journal:  J Mol Cell Cardiol       Date:  2013-01-18       Impact factor: 5.000

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.